Shaily Engineering Plastics

Shaily Engineering delivered a strong Q3 FY26 with revenue of ₹251 croreCurrent reported value: ₹251 crore. No comparable prior figure is available in the source record. (+27Current reported value: 27. No comparable prior figure is available in the source record.% YoY) and EBITDA of ₹66 croreCurrent reported value: ₹66 crore. No comparable prior figure is available in the source record. (+43% YoY), driven by healthcare segment revenue doubling to ₹104 croreCurrent ₹104 crore. Reported change: +139% YoY. (42% of mix). EBITDA margin expanded 310 bpsCurrent reported value: 310 bps. No comparable prior figure is available in the source record. to 26.5Current reported value: 26.5. No comparable prior figure is available in the source record.%, though consolidated margins were temporarily impacted by delayed milestone income from UK/UAE operations. Healthcare growth was fueled by GLP-1 pen injector supplies for commercial launches in Canada, Brazil, India, and other markets. Management announced a new Abu Dhabi facility (₹300-350 crore capex, 75M unit capacity, operational by Q4 FY28) to meet surging demand, with 50-60% capacity already backed by take-or-pay contracts. Consumer segment declined 13% YoY due to weak European demand. Key risk: delays in qualifying high-speed pen assembly lines could constrain near-term revenue ramp-up.